CIDP - PowerPoint PPT Presentation

1 / 47
About This Presentation
Title:

CIDP

Description:

cidp 2001 cidp - cidp ... – PowerPoint PPT presentation

Number of Views:208
Avg rating:3.0/5.0
Slides: 48
Provided by: Them170
Category:
Tags: cidp | mppt

less

Transcript and Presenter's Notes

Title: CIDP


1
CIDP
  • 2001? ????

2
CIDP
  • ??????????????
  • ????-?????
  • ???????????

3
CIDP
?????
1
?????MRI
2
?????????
3
???????
4
4
????
DW3
B7
HLAA
CIDP
DRw3
DR2
5
????
?????
CIDP
6
????
  • ?????????????
  • Schwann????,????????

7
(No Transcript)
8
(No Transcript)
9
(No Transcript)
10
????
T 5,000 ? 22,000?
2-7.7/100,000.
CIDP
1.44.7
5060?????
?????
????
?????????
11
????
????????????
?????
??????
??????????????? ????????????????
?????????????? ??????,????? ????????????
MRI?????????? ?????????? ??
???? ?? ????? ???????
12
???? Dyck
  • ?????15
  • ?????15
  • ?????34
  • ??????34

13
MRI
  • CIDP is a chronic progressive polyradiculoneuropat
    hy. On MRI
  • the cranial nerves and nerve roots can be
    enhancing and prominently enlarged. In some
    cases, involvement of cranial nerves VII and VIII
    can simulate bilateral acoustic neuromas seen in
    NF2.
  • Enlargement of the spinal nerve roots can
    simulate multiple neurofibromas seen in NF1.
  • Patients with CIDP tend to have a slow
    progressive clinical course that is often
    misdiagnosed initially.

14
MRI
  • 41-year-old man with leg weakness, decreased
    dexterity in hands, and numbness in umbilical and
    perineal regions.

15
MRI
16
MRI
17
??
CIDP
??
18
????
Nicolas ?Thaisetthawatkul
??/????
INCAT ?????????? ????????
AAN ????????
19
ANN
  • ? AAN ???, CIDP ???????,??????,????????????,?????
    ???,??????????

20
ANN
  • A. ???CIDP????
  • 1. ????(mandatory)(1)????????????????????????
    ?-????(???????????),???2??????(2)????????(?????)
    2. ????(exclusive)(1)???????(mutilation),???????
    ????,?????????????????,?????????????(2)??(???)??
    ??(sensory level)(3)????????

21
ANN
  • B. ???CIDP?????1. ????CIDP?????2.
    ?????(????)(1)???lt10/mm3(??HIV???)lt50/mm3(??HIV?
    ??)(2)????(VDRL)??C. ??CIDP?????1.
    ?????CIDP?????2. ????(1)??????????????????????,
    ?????(5??????)??????(50??,???4????????????gt12)
    (2)???????(???????????)???????Schmann????????????
    ???(?????????,????????????????????)????????????

22
ANN
  • ???????1. ?????????????????????,??????????,????4
    ????3?(1)2?????????????1)?????????80????????
    ??????80??2)?????????80????????????70??(2)??
    ?????????????????????????(temporal
    dispersion)???????????,??????????,???????????1
    )??????(partial conduction block)??????????????
    lt15,????????????????????gt20?2)???????????(abnor
    mal temporal dispersion)???????(possible
    conduction block)??????????????gt15,??????????
    ?????????gt20,??????????????(3)2?????????????1)?
    ?????????80???????????????1252)??????????80?
    ??????????????150(4)2???????F??????F??????(101
    5???)1)??????????80,?F??????????????1202)?????
    ?????80,?F??????????????150

23
ANA???
  • ?????,???1/3-2/3?CIDP???,?????CIDP??????

24
??????????? ???????? INCAT
????????????? ??????????????
INCAT
???????2????
?????????
25
INCAT
26
INCAT
  • ??????????48?CIDP???????????????,? 21
    ????????? CIDP ? ??????????????????????????
    ?????????,????????? CIDP?????? ???????????????????
    ??? ,??????????

27
CIDP?????(?)
28
CIDP????(?)
29
(No Transcript)
30
CIDP????(?)
AIDP 3A?
????? 1?
???????? 2?
????? 4?
??? 3?
CIDP
??????? 2?
???? 1?
31
(No Transcript)
32
??????
33
??????
34
CIDP????
???
????????????
CIDP
??
Sjogren ???
????
AIDS
???
35
?????CIDP????CIDP
???????,I- CIDP ???DM - CIDP ????????
36
CIDP????
MASAM
37
???CIDP
  • CIDP ????????????????? CIDP ????????,??????????,
    ?????????

38
????????(MMN)
  • MMN ????CIDP ?????????????? ? CIDP ?????,MMN
    ?????????????????????, ?????????? ??, MMN
    ????IVIg ??????????
  • ?????,???-??????MMN???? IVIg ?????,????????
    IVIg???????? ???, Van den Berg?40???MMN??,??????,?
    ?,???-??? ?????,Federico ?41???,?IVIg
    ?????,16????? 11?(69)????????????????????????????
    ??????? ?????????MMN?????????????????,
    ???????CIDP?????

39
????????????????? (MADSAM)
  • MADSAM ??????, ?????Lewis-Sumner??????????????????
    ???MADSAM ??? ?????????????????, ??????
    ,????,????????? , ??????, F- ??????

40
??
?????100mg/d,24????
????40mg/d,????4d??20mg/d,?12d10mg/d,?12d,28d???
??

????IVIG??0.4g/kg,??5d
????(PE)??????????
41
IVIGMPPT
  • ????????IVIGMPPT????CIDP?,???????????????MPPT?
  • MPPT?????????????????,?????????????
  • IVIG?IG?75,????????????,???????????????,?????????
    ????????????????,????????????????,??????????????

42
.
  • high-dose intermittent intravenous
    methylprednisolone.
  • ???????????????

43
high-dose intermittent intravenous
methylprednisolone.
  • A retrospective medical record review between
    1992 and 2003 of outcomes in CIDP, comparing
    patients in 3 cohorts depending on whether their
    primary treatment was IVMP, IVIg, or oral
    immunosuppression with prednisone or
    cyclosporine. SETTING Washington University
    Neuromuscular Disease Center (St Louis, Mo),
    outpatient and inpatient records.
  • PATIENTS Patients with clinical and
    electrophysiologic evidence of CIDP were
    identified. Of 57 patients, 39 had sufficient
    data for full analysis. MAIN OUTCOME MEASURES
    Quantitative muscle testing with a handheld
    dynamometer. Medication profiles and adverse
    effects were also recorded. RESULTS There was no
    significant difference in the mean improvement in
    quantitative muscle testing at 6 months or at the
    last clinic visit (an average of 4.5 years later)
    among the 3 groups. Fewer patients treated with
    oral immunosuppression improved at 6 months, but
    at the last visit, 81 to 88 improved in all 3
    groups. Less weight gain and fewer cushingoid
    features affected patients treated with IVMP
    (19) compared with patients treated with oral
    prednisone (58). CONCLUSIONS Treatment of
    patients with CIDP using high-dose intermittent
    IVMP results in improved strength equal to that
    with IVIg and oral prednisone. The frequency of
    occurrences of weight gain and cushingoid
    features with IVMP is less than that with oral
    prednisone. Intravenous methylprednisolone should
    be considered for initial and long-term therapy
    in CIDP when patients have disability due to
    weakness.

44
????
6???4.5??????
?????
IVMP
IVIG
?
????,????
????,????
8188?????????
45
  • IVMP????CIDP???????

46
CIDP???(52?)
  • ????
  • ???????

???????
??????
  • ???219??

47
Thank You !
Write a Comment
User Comments (0)
About PowerShow.com